Morepen Laboratories Ltd (NSE:MOREPENLAB) Share Price

Company Profile

Business description
Morepen Laboratories Ltd is in the business of manufacturing, producing, developing, and marketing various Active Pharmaceutical Ingredients (APIs), branded and generic formulations, and also Home Health products. Some of the products offered by the company include various drug formulations, APIs, digital thermometers, heat belts, pulse oximeters, nutritional tablets, pain sprays, and others. The company operates in a single segment namely, Pharmaceuticals. Geographically, the company derives maximum revenue from India and the rest from the United States of America, and the Rest of the world.
Contact
Udyog Vihar-III, Sector-20
2nd Floor, Tower C, DLF Cyber Park
GurugramHR122016
IND
T: +91 1244892000
https://www.morepen.com
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 March 2026
Employees
2,599

Recommended

Sales growth at CSL was lower than expected but streamlining the business has its perks.

Shane Ponraj, CFA | 19 August 2025

Results were softer than expected.

Jon Mills, CFA | 19 August 2025

a2Milk announced an acquisition and a divestiture as it aims to take a bigger slice of China’s baby formula market.

Angus Hewitt, CFA | 19 August 2025

Index	Last price	Change	% Change
All Ordinaries	9,197.40	23.60	0.26%
CAC 40	7,979.08	95.03	1.21%
DAX 40	24,423.07	108.30	0.45%
Dow JONES (US)	44,922.27	10.45	0.02%
FTSE 100	9,189.22	31.48	0.34%
HKSE	25,016.62	106.28	-0.42%
NASDAQ	21,314.95	314.82	-1.46%
Nikkei 225	42,871.06	675.23	-1.55%
NZX 50 Index	13,072.25	143.57	1.11%
S&P 500	6,411.37	37.78	-0.59%
S&P/ASX 200	8,934.20	38.00	0.43%
SSE Composite Index	3,731.58	4.29	0.12%